Insider filing · ETON
James R. Gruber
Chief Financial Officer
profile →
Eton Pharmaceuticals, Inc.
ETON · Healthcare · 14 filings in 24 months
ticker →
James R. Gruber sold $632K of Eton Pharmaceuticals (ETON)
Executed Aug 19 2025, disclosed Aug 20 2025, 1 day later.
Value, as filed
$632K
39,082 sh × $16.16
Executed
Aug 19 2025
the trade date, as filed
Disclosed
Aug 20 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JGJames R. Gruber (Chief Financial Officer) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Eton Pharmaceuticals, Inc. (ETON). The largest single filing was $632K of ETON (39,082 sh × $16.16, as filed), executed Aug 19 2025.
The name
ETONHealthcare · Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→